S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

VRNA Verona Pharma Plc

22.18

1.11 (5.27%)

After Hours

Last Updated: 05:59:59

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

null

Verona Pharma (NASDAQ:VRNA)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more Verona Pharma Charts.

Verona Pharma (NASDAQ:VRNA)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more Verona Pharma Charts.

Verona Pharma Plc News

Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update
Thursday 25 July 2024 (14 hours ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Saturday 13 July 2024 (2 weeks ago) • Edgar (US Regulatory)

Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)
Thursday 27 June 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 10 May 2024 (3 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 10 May 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 9 May 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 9 May 2024 (3 months ago) • Edgar (US Regulatory)

Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
Thursday 9 May 2024 (3 months ago) • GlobeNewswire Inc.

Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
Thursday 9 May 2024 (3 months ago) • GlobeNewswire Inc.

Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024
Thursday 2 May 2024 (3 months ago) • GlobeNewswire Inc.

Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update
Thursday 25 April 2024 (3 months ago) • GlobeNewswire Inc.

Form PRE 14A - Other preliminary proxy statements
Saturday 9 March 2024 (5 months ago) • Edgar (US Regulatory)

More Verona Pharma Plc News Articles

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions